
Lupin Limited has informed the Exchange regarding a press release dated May 27, 2021, titled "Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated May 27, 2021, titled "Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin